Veterinary Research

For over a decade, Transpharmation has been providing research and development services in the companion animal market. Our scientists and veterinarians are leading experts in the field of cognition and general behaviour, anxiety, aging, and life-span development.

Our colony encompasses a wide variety of companion animal populations, including both general research cohorts and disease-specific groups with naturally occurring conditions such as osteoarthritis, mitral valve disease, periodontal disease, atopic dermatitis and other age-associated disorders. In addition, we offer induced disease models, including type I diabetes, obesity, and gut dysbiosis, providing versatile and clinically relevant platforms to support therapeutic development across multiple indications.

Leading veterinary medicine developers trust us to help guide and conduct innovative research studies and early proof-of-concept evaluations that provide evidence to support product claims and regulatory submissions.

Our goal is to help evaluate and develop innovative products which improve the quality of life of companion dogs and cats. A summary of populations and example endpoints are summarized below.